Suberoylanilide Hydroxamic Acid
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Enzyme Inhibitor ->
Histone Deacetylase Inhibitor -> Suberoylanilide Hydroxamic Acid
Suberoylanilide Hydroxamic Acid Definition
A synthetic hydroxamic acid derivative with antineoplastic activity. Vorinostat, a second generation polar-planar compound, binds to the catalytic domain of the histone deacetylases (HDACs). This allows the hydroxamic moiety to chelate zinc ion located in the catalytic pockets of HDAC, thereby inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors. Hyperacetylation of histone proteins results in the upregulation of the cyclin-dependant kinase p21, followed by G1 arrest. Hyperacetylation of non-histone proteins such as tumor suppressor p53, alpha tubulin, and heat-shock protein 90 produces additional anti-proliferative effects. This agent also induces apoptosis and sensitizes tumor cells to cell death processes. Vorinostat crosses the blood-brain barrier.
Suberoylanilide Hydroxamic Acid Synonyms
Vorinostat, L-001079038, N-Hydroxy-N'-phenyloctanediamide, SAHA, Suberanilohydroxamic Acid, Suberoylanilide Hydroxamic Acid, VORINOSTAT, Zolinza, suberoylanilide hydroxamic acid
Terms in Suberoylanilide Hydroxamic Acid category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.